Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JAROSLAW PAWEL MACIEJEWSKI

Allopathic & Osteopathic Physicians Internal Medicine Hematology

NPI
1831299908
CMS profile
264330
Location
CLEVELAND, OH

General Payments · PY2018–2024

$235,065.28

  • Reported across 201 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$27,111.47

29 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $14,305.91 10
Alexion Pharmaceuticals, Inc. $8,661.81 12
Genentech, Inc. $2,280.00 2
E.R. Squibb & Sons, L.L.C. $1,500.00 1
Apellis Pharmaceuticals, Inc. $189.77 2
SOBI, INC $173.98 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $48,451.11 46
PY2019 $20,801.28 31
PY2020 $56,534.75 20
PY2021 $12,032.25 9
PY2022 $13,811.17 26
PY2023 $56,323.25 40
PY2024 $27,111.47 29

Payment records · PY2024 (29)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $2,340.00 01/03/2024 Consulting Fee Undisputed 01/23/2026 1094002091 CMS
Alexion Pharmaceuticals, Inc. $18.60 02/15/2024 Food and Beverage Undisputed 01/23/2026 1093955131 CMS
Alexion Pharmaceuticals, Inc. $19.82 02/16/2024 Food and Beverage Undisputed 01/23/2026 1093931657 CMS
Alexion Pharmaceuticals, Inc. $13.74 02/19/2024 Food and Beverage Undisputed 01/23/2026 1094011827 CMS
Alexion Pharmaceuticals, Inc. $69.12 04/09/2024 Food and Beverage Undisputed 01/23/2026 1093887157 CMS
Alexion Pharmaceuticals, Inc. $19.68 05/14/2024 Food and Beverage Undisputed 01/23/2026 1094011834 CMS
Alexion Pharmaceuticals, Inc. $19.67 07/02/2024 Food and Beverage Undisputed 01/23/2026 1093977110 CMS
Alexion Pharmaceuticals, Inc. $2,145.00 07/30/2024 Consulting Fee Undisputed 01/23/2026 1093986691 CMS
Alexion Pharmaceuticals, Inc. $24.34 08/27/2024 Food and Beverage Undisputed 01/23/2026 1093917064 CMS
Alexion Pharmaceuticals, Inc. $3,900.00 10/08/2024 Consulting Fee Undisputed 01/23/2026 1093916103 CMS
Alexion Pharmaceuticals, Inc. $24.67 11/05/2024 Food and Beverage Undisputed 01/23/2026 1093943314 CMS
Alexion Pharmaceuticals, Inc. $67.17 12/07/2024 Food and Beverage Undisputed 01/23/2026 1094006081 CMS
Apellis Pharmaceuticals, Inc. $129.00 02/15/2024 Food and Beverage Undisputed 01/23/2026 1154022359 CMS
Apellis Pharmaceuticals, Inc. $60.77 03/23/2024 Food and Beverage Undisputed 01/23/2026 1154022361 CMS
E.R. Squibb & Sons, L.L.C. $1,500.00 12/02/2024 Consulting Fee Undisputed 01/23/2026 1101694331 CMS
Genentech, Inc. $1,520.00 02/08/2024 Consulting Fee Undisputed 01/23/2026 1133027128 CMS
Genentech, Inc. $760.00 03/07/2024 Consulting Fee Undisputed 01/23/2026 1133027132 CMS
Novartis Pharmaceuticals Corporation $800.00 02/09/2024 Consulting Fee Undisputed 01/23/2026 1086961298 CMS
Novartis Pharmaceuticals Corporation $800.00 03/13/2024 Consulting Fee Undisputed 01/23/2026 1086961336 CMS
Novartis Pharmaceuticals Corporation $1,600.00 03/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1086961300 CMS
Novartis Pharmaceuticals Corporation $1,600.00 04/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1086961308 CMS
Novartis Pharmaceuticals Corporation $1,600.00 06/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1086961310 CMS
Novartis Pharmaceuticals Corporation $2,000.00 06/18/2024 Consulting Fee Undisputed 01/23/2026 1086961334 CMS
Novartis Pharmaceuticals Corporation $2,600.00 06/24/2024 Consulting Fee Undisputed 01/23/2026 1087110136 CMS
Novartis Pharmaceuticals Corporation $2,000.00 08/23/2024 Consulting Fee Undisputed 01/23/2026 1086961332 CMS
Novartis Pharmaceuticals Corporation $105.91 12/07/2024 Food and Beverage Undisputed 01/23/2026 1086961330 CMS
Novartis Pharmaceuticals Corporation $1,200.00 12/08/2024 Consulting Fee Undisputed 01/23/2026 1086961338 CMS
SOBI, INC $23.98 02/08/2024 Food and Beverage Undisputed 01/23/2026 1141420386 CMS
SOBI, INC $150.00 12/08/2024 Food and Beverage Undisputed 01/23/2026 1141431639 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.